The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature (Q35216052)

7 August 2017

8 references

3 April 2019

19 June 2019

31 July 2019

2 August 2019

7 August 2019

28 September 2019

15 December 2019

18 December 2019

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature (English)

1 reference

7 August 2017

2 references

3 April 2019

19 June 2019

cell surface receptor

1 reference

31 July 2019

6 references

31 July 2019

7 August 2019

2 August 2019

28 September 2019

15 December 2019

18 December 2019

proto-oncogene protein

1 reference

2 August 2019

1 reference

7 August 2019

1 reference

28 September 2019

1 reference

15 December 2019

1 reference

18 December 2019

1 reference

A-P Meert

1

1 reference

7 August 2017

B Martin

2

1 reference

7 August 2017

M Paesmans

3

1 reference

7 August 2017

T Berghmans

4

1 reference

7 August 2017

C Mascaux

5

1 reference

7 August 2017

J-M Verdebout

6

1 reference

7 August 2017

P Delmotte

7

1 reference

7 August 2017

J-J Lafitte

8

1 reference

7 August 2017

J-P Sculier

9

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

British Journal of Cancer

7 August 2017

15 September 2003

8 references

3 April 2019

19 June 2019

31 July 2019

2 August 2019

7 August 2019

28 September 2019

15 December 2019

18 December 2019

9 references

7 August 2017

3 April 2019

19 June 2019

31 July 2019

2 August 2019

7 August 2019

28 September 2019

15 December 2019

18 December 2019

89

1 reference

7 August 2017

issue

6

1 reference

7 August 2017

page(s)

959-965

1 reference

The role of EGF-R expression on patient survival in lung cancer: a systematic review with meta-analysis

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non-small cell lung cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Prognostic value of the quantified expression of p185 in non-small cell lung cancer.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Basic science of HER-2/neu: a review

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Molecular pathologic substaging in 244 stage I non-small-cell lung cancer patients: clinical implications.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Sialomucin expression is associated with erbB-2 oncoprotein overexpression, early recurrence, and cancer death in non-small-cell lung cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Prediction of recurrence by quantification of p185neu protein in non-small-cell lung cancer tissue

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Lack of prognostic significance of epidermal growth factor receptor and the oncoprotein p185HER-2 in patients with systemically untreated non-small-cell lung cancer: an immunohistochemical study on cryosections

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Sensitivity of HER-2/neu antibodies in archival tissue samples: potential source of error in immunohistochemical studies of oncogene expression.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Molecular and biological factors in the prognosis of non-small cell lung cancer

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

The medical review article: state of the science

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Beta blockade during and after myocardial infarction: an overview of the randomized trials

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

p185neu expression in human lung adenocarcinomas predicts shortened survival

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Prognostic value of oncoproteins for the survival of patients with nonsmall cell lung carcinomas

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Biological markers in non-small cell lung cancer. Retrospective study of 10 year follow-up after surgery.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Epidermal growth factor receptor and HER2-neu mRNA expression in non-small cell lung cancer Is correlated with survival.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Study of prognostic predictors for non-small cell lung cancer.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Prognostic significance of the expression of c-fos, c-jun and c-erbB-1 oncogene products in human squamous cell lung carcinomas

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

c-erbB-2 gene product associates with catenins in human cancer cells.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Migration of fresh human malignant astrocytoma cells into hydrated gel wafers in vitro

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2376951

Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma

26 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601252

Vascular endothelial growth factor and other biological predictors related to the postoperative survival rate on non-small cell lung cancer

21 January 2018

1 reference

12 December 2020

The extracellular domain of the c-erbB-2 oncoprotein is released from tumor cells by proteolytic cleavage

1 reference

12 December 2020

A biologic risk model for stage I lung cancer: immunohistochemical analysis of 408 patients with the use of ten molecular markers

1 reference

12 December 2020

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer

1 reference

12 December 2020

Localized adenocarcinoma of the lung: oncogene expression of erbB-2 and p53 in 150 patients

1 reference

12 December 2020

Predictive survival markers in patients with surgically resected non-small cell lung carcinoma

1 reference

12 December 2020

Use of possible synergistic expression of p53 and p185 as a prognostic tool for stage I non-small-cell lung cancer

1 reference

12 December 2020

Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer

1 reference

12 December 2020

Prognostic value of K-ras mutations, ras oncoprotein, and c-erb B-2 oncoprotein expression in adenocarcinoma of the lung

1 reference

12 December 2020

Prognostic influence of the co-expression of epidermal growth factor receptor and c-erbB-2 protein in human lung adenocarcinoma

1 reference

12 December 2020

Serum Level and Tissue Expression of c-erbB-2 Protein in Lung Adenocarcinoma

1 reference

12 December 2020

HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma. Impact on long-term survival

1 reference

12 December 2020

Do molecular markers predict survival in non-small-cell lung cancer?

1 reference

12 December 2020

Analysis of neuroendocrine markers, HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small cell lung cancer: a Cancer and Leukemia Group B study

1 reference

12 December 2020

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor

1 reference

12 December 2020

The interactive effect of Ras, HER2, P53 and Bcl-2 expression in predicting the survival of non-small cell lung cancer patients

1 reference

12 December 2020

Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma

1 reference

12 December 2020

Correlations between intrinsic chemoresistance and HER-2/neu gene expression, p53 gene mutations, and cell proliferation characteristics in non-small cell lung cancer cell lines

1 reference

12 December 2020

Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis

1 reference

12 December 2020

Clinicopathologic analysis of k-ras, p53, and ERBB-2 gene alterations in pulmonary adenocarcinoma

1 reference

12 December 2020

p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma

1 reference

12 December 2020

Immunocytochemical markers in stage I lung cancer: relevance to prognosis

1 reference

12 December 2020

Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma

1 reference

12 December 2020

Potential role ofbcl-2 as a suppressor of tumour angiogenesis in non-small-cell lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601252

1 reference

7 August 2017

1 reference

7 August 2017

1 reference